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Abstract: Human milk provides essential substrates for the optimal growth and development of a
breastfed infant. Besides providing nutrients to the infant, human milk also contains metabolites
which form an intricate system between maternal lifestyle, such as the mother’s diet and the gut
microbiome, and infant outcomes. This study investigates the variation of these human milk
metabolites from five different countries. Human milk samples (n = 109) were collected one month
postpartum from Australia, Japan, the USA, Norway, and South Africa and were analyzed by
nuclear magnetic resonance. The partial least squares discriminant analysis (PLS-DA) showed
separation between either maternal countries of origin or ethnicities. Variation between countries
in concentration of metabolites, such as 2-oxoglutarate, creatine, and glutamine, in human milk,
between countries, could provide insights into problems, such as mastitis and/or impaired functions
of the mammary glands. Several important markers of milk production, such as lactose, betaine,
creatine, glutamate, and glutamine, showed good correlation between each metabolite. This work
highlights the importance of milk metabolites with respect to maternal lifestyle and the environment,
and also provides the framework for future breastfeeding and microbiome studies in a global context.
Nutrients 2018, 10, 1151; doi:10.3390/nu10091151 www.mdpi.com/journal/nutrients
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1. Introduction
Human milk provides all of the essential nutrients and bioactive substrates required for optimal
growth and development of the nursing infant [1]. This includes not only large immunoglobulins and
proteins, but also numerous low molecular weight substances, such as simple sugars and complex
human milk oligosaccharides (HMOs), amino acids, short-chain fatty acids, and other energy metabolic
pathway intermediates [2]. These nutrients work as part of a complex functional unit, operating in
concert with intestinal enzymes to influence infant physiology. Many metabolites, such as HMOs,
lactose, and other milk sugars, are also fermented by gut microbiota to generate additional metabolites.
Variation in the human milk metabolome, namely with HMOs, is seen by maternal phenotype and
diet [3]. Despite this, there are still only a few studies reporting on the determinants of small molecule
concentrations in human milk or their role, and only limited studies on global regional differences in
other milk components [4,5].
Patterns of infant growth are strong predictors of future cognitive performance and
cardiometabolic health [6–8]. Breastfeeding may protect from rapid growth during infancy and
the risk for overweight/obesity, diabetes, and high blood pressure [9]; however, this may vary with
compositional factors in human milk [10]. Because human milk metabolites influence infant gut
microbial composition, and gut microbial dysbiosis has been linked to future overweight [11,12],
geographic variations in small milk molecules can conceivably predict regional differences in infant
gut microbial development, infant growth, and future health. The activity of some milk metabolites
directly reflects maternal diet, and hence would be a function of regional differences in dietary
intake [13]. Taking as an example immune system activation of spillover lactose in the colon secondary
to lactase deficiency in the small intestine [14], the activity of still other milk metabolites may be
subject to regional differences in host genetics. With an aim to learn more about these less well-studied
small molecular weight metabolites, we undertook a descriptive study of human milk metabolomics,
comparing women from diverse geographical locations. Healthy women without atopic conditions
were the focus of the comparison. We found regional differences in milk metabolites related to lactation
performance that differentiated South African women from women from other countries.
2. Materials and Methods
With representation across ethnicity, maternal atopy status, and infant sex, 109 milk samples
collected one month after birth were selected from six existing international cohorts: Perth, Australia
(n = 29 from 2 cohorts which include 21 atopic mothers, i.e., Perth #1, [15] and 8 non-atopic mothers, i.e.,
Perth #2) [16]; Chiba, Japan (n = 12); Detroit, USA (n = 18) [17]; Oslo, Norway (n = 40) [18]; and Cape
Town, South Africa (n = 10) [4]. The one-month postpartum time period was selected because human
milk composition has stabilized by then [2]. Maternal atopy status was defined according to maternal
report of asthma, eczema, allergies, or other atopic diseases, or at least one blood allergen-specific IgE
level ≥ 35 kU/L for dust mite, dog, cat, Timothy grass, ragweed, Alternaria alternate, egg, or German
cockroach. Research ethics approval was obtained from the Human Research Ethics Committee of The
University of Western Australia, Human Research Ethics Committee of the Princess Margaret Hospital,
Committee on Human Research of Chiba University, Institutional Review Board at Henry Ford Health
System, Norwegian Regional Committees for Medical and Health Research Ethics, and University of
Cape Town Human Research Ethical Committee.
Before sample collection, the mothers were given oral and written instructions for standardized
collection of samples. Human milk samples were collected manually or with an electric breast pump
into a sterile tube. Prior to collection, nipples and mammary areola were cleaned with soap and sterile
water, and for the samples from South Africa, the area was additionally soaked with chlorhexidine to
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reduce contamination by skin microbes. All of the samples were kept frozen at−20 ◦C until delivery to
the laboratory and then stored at−20 ◦C or−80 ◦C until further analysis. All the samples were shipped
to Edmonton, Canada for storage, processing and Nuclear Magnetic Resonance (NMR) analysis at The
Metabolomics Innovation Centre.
Milk metabolite levels were determined by NMR because of its high reproducibility and coverage
of a large range of metabolites. Prior to NMR spectroscopy, milk samples were thawed on ice and
mixed thoroughly. Approximately 500 µL of each sample was filtered to remove residual lipids and
protein using Amicon Ultra 0.5 mL 3-kDa cutoff spin filter (Millipore Sigma, Burlington, MA, USA).
The filtration was performed at 10,000× g for 15 min at 4 ◦C. Then, a 350 µL clear filtrate was placed
in a 1.5-mL Eppendorf tube, followed by the addition of 70 µL of D2O and 60 µL of standard buffer
solution (585 mM NaHPO4 (pH 7.0), 11.667 mM disodium-2,2-dimethyl-2-silapentane-5-sulfonate
(DSS), and 0.47% NaN3 in H2O). The samples (460 µL) were then transferred to a regular NMR tube
for subsequent NMR spectral analysis. All 1H-NMR spectra were collected on a Varian 500 MHz Inova
spectrometer equipped with a 5-mm HCN Z-gradient pulsed-field gradient cryogenic probe. 1H-NMR
spectra were acquired at 25 ◦C using the first transient of the Varian tnnoesy pulse sequence, which
was chosen for its high degree of selective water suppression and quantitative accuracy of resonances
around the solvent. Water suppression pulses were calibrated to achieve a bandwidth of 80 G. Spectra
were collected with 128 transient and 8 steady-state scans using a 4-s acquisition time (48,000 complex
points) and a 1-s recycle delay. Quality control (QC) mixtures which consisted of 4 metabolites at 1 mM
were analyzed for every 20 to 25 samples, and a relative standard deviation of <2% was observed.
Before spectral analysis, all free induction decays were zero-filled to 64,000 data points and line
broadened to 0.5 Hz. The methyl singlet produced by a known quantity of DSS was used as an internal
standard for chemical shift referencing (set to 0 ppm) and for quantification. All 1H-NMR spectra were
processed and analyzed using the Chenomx NMR Suite Professional software package version 8.1
(Chenomx Inc., Edmonton, AB, Canada). The Chenomx NMR Suite software allows for qualitative
and quantitative analysis of an NMR spectrum by manually fitting spectral signatures from an internal
database to the spectrum. Typically, 90% of visible peaks were assigned to a compound, and more than
90% of the spectral area could be routinely fit using the Chenomx spectral analysis software. Most of
the visible peaks were annotated with a compound name and expressed as µmol/L.
Statistical Analysis
Partial Least Square Discriminant Analysis (PLS-DA) was created using the Excel add-in Multibase
2015 package (Numerical Dynamics, Tokyo, Japan). PLS-DA was performed in order to maximize the
separation between the different countries as well as the ethnicities of the mothers. Data preparation
was made using the scaling method of standard deviations. Sample scatterplot and loading plots were
compared where significant variables which contribute to sample distribution can be easily identified.
Statistical analyses were carried out using R studio 1.1.414 (Rstudio Inc., Boston, MA, USA) with
package nlme for linear mixed models to test for significant differences between the milk metabolites
among different countries, and among ethnicities of the mothers. Milk metabolite levels were compared
with each other using the Pearsons correlation across all the non-atopic mothers using Package
corrplot [19]. Differences are considered to be significant if p < 0.05.
3. Results
Of the 109 participating women, 69% were Caucasian, 51% were nursing male infants, and 43%
had a history of atopy; this comparison oversampled atopic women and their additional results are
the subject of another paper. The majority of South African women were of mixed race and all were
non-atopic; most of the comparator cohorts were of Caucasian ancestry. Of the women in the US
cohort, 39% were African American (labelled as Black) and only one African-American woman was
non-atopic. All women had delivered vaginally and did not receive intrapartum antibiotics.
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3.1. Milk Metabolite Clusters by Country
A total of 28 metabolites were identified in the human milk of our descriptive study, including
sugars (fucose, glucose, lactose), amino acids (alanine, glutamine, glutamate, glycine, isoleucine,
leucine, valine), choline and its metabolites, and energy metabolites (acetone, citrate, creatine, creatine
phosphate, creatinine, lactate, 2-oxoglutarate, pyruvate, succinate), as shown in Figure 1. Most of the
measured metabolites were within the range of those reported in other studies at a comparable time
postpartum [20,21].
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African and Australian women. No country differences were observed in other milk sugars (glucose
or fucose) or other energy metabolite (i.e., succinate) concentrations.
In addition, a statistical significance was also noted for lower milk levels of glutamine (p < 0.001)
in Norwegian versus US women. Japanese women had significantly higher milk levels of pyruvate
(p < 0.01) and lactate (p < 0.01) than Norwegian women. Milk levels of methanol were significantly
lower (p < 0.02) in Norway versus all other countries.
Table 1. Comparison of milk metabolites concentrations (µmol/L) by country of origin.
MEAN (SD)
Metabolites/Countries South Africa Japan Norway US Perth #2
2-Oxoglutarate 79.6 (25.6) 79.1 (49.2) ## 30.5 (31.2) *** 39.0 (12.7) * 47.5 (19.9)
Acetone 13.2 (6.4) 19.8 (15.7) 10.8 (7.6) 11.4 (3.3) 13.3 (7.5)
Alanine 161.0 (93.5) 233.6 (96.8) 208.1 (84.5) 240.1 (91.9) 203.2 (48.4)
Betaine 668.1 (201.8) 355.3 (367.1) 180.4 (318.8) *** 408.4 (567.8) 58.8 (6.6) ***
Caprate 108.6 (124.7) 193.1 (216.3) 121.5 (120.3) 60.0 (90.6) 114.0 (42.9)
Caprylate 157.1 (137.2) 357.6 (497.0) 131.6 (207.1) 92.7 (132.5) 82.7 (47.1)
Choline 322.1 (194.9) 192.0 (128.3) 184.1 (163.7) 133.0 (77.0) 138.5 (71.1)
Citrate 5614 (3920) 2830 (1313) * 2718 (1361) *** 3642 (1272) 2856 (836.1) *
Creatine 274.7 (342.9) 60.3 (28.4) * 63.9 (26.9) *** 56.8 (23.4) * 66.5 (19.0) *
Creatine phosphate 49.6 (54.3) 45.2 (31.1) 20.6 (13.1) * 42.0 (12.7) 23.9 (7.6)
Creatinine 108.8 (82.7) 42.9 (15.4) ** 43.7 (15.6) *** 57.3 (22.9) * 45.0 (5.7) **
Formate 83.4 (79.4) 112.2 (127.8) 902.0 (1695.2) 91.9 (55.7) 127.1 (24.9)
Fucose 278.5 (373.5) 570.9 (482.9) 330.5 (252.5) 344.4 (216.4) 382.3 (277.5)
Glucose 1347 (852.9) 1563 (1327) 926.4 (747.8) 1697 (413.5) 1699 (935.9)
Glutamate 858.9 (491.3) 1296 (565.8) 1467 (835.2) 1573 (830.2) 1554 (369.4)
Glutamine 282.0 (150.9) 103.0 (88.1) 101.9 (119.0) 514.2 (618.2) ### 207.6 (178.2)
Glycine 2796 (759.9) 3135 (1373) 2512 (1191) 1641 (1777) 1919 (949.5)
Guanidoacetate 4771 (1048) 3777 (1747) 3373 (2944) 3435 (1770) 1622 (286.5) *
Isoleucine 20.8 (12.2) 24.1 (25.9) 24.2 (21.1) 10.9 (2.6) 12.0 (4.0)
Lactate 213.7 (63.1) 3215 (5561) **## 443.5 (693.6) 137.8 (102.0) 125.7 (41.5)
Lactose 189,874 (34,234) 139,161 (83,333) 101,351 (84,404) * 161,160 (123,638) 83,524 (23,509) *
Leucine 33.7 (21.1) 49.9 (61.2) 66.2 (76.2) 30.9 (8.9) 34.0 (7.8)
Methanol 78.0 (17.6) 97.7 (49.2) ### 46.1 (19.3) *** 89.2 (6.7) ### 72.0 (6.8) #
Phosphocholine 636.9 (328.6) 784.7 (470.6) 463.7 (326.7) 698.3 (231.2) 488.4 (145.6)
Pyruvate 53.3 (29.5) 68.6 (69.8) ## 20.0 (26.3) * 31.7 (39.7) 6.3 (2.5) *
Succinate 48.3 (67.0) 47.9 (25.9) 210.8 (515.7) 21.2 (9.6) 49.3 (15.7)
Valine 35.3 (11.9) 63.9 (33.5) 65.6 (32.7) * 50.2 (21.1) 57.4 (17.6)
Glycerophosphocholine 797.6 (439.3) 645.0 (393.0) 414.9 (346.0) * 589.2 (239.7) 517.4 (118.5)
# metabolite differences
with South Africa na 4 11 3 7
# metabolite differences
with Norway - 4 na 2 1
* p < 0.05, ** p < 0.01, *** p < 0.001 when reference = South Africa; # p < 0.05, ## p < 0.01, ### p < 0.001 when
reference = Norway; na: not applicable.
3.3. Milk Metabolite Correlations
Correlations between milk metabolites are reported in Figure 3. Both lactose and betaine were
positively correlated with citrate, creatine, and the phosphocholines; milk lactose levels significantly
rose with those of 2-oxoglutarate.
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3.4. Milk Metabolite Clusters by Race/Ethnicity
Metabolite variation by ethnicity in the PLS plots was similar to country differences, showing
three clusters of milk composition: Black, Caucasian and Asian (Figure 4). Milk lactate differentiated
the Asian population from the rest. 2-Oxoglutarate and creatine were the main drivers of the milk
cluster in the Black population, whereas the main milk metabolites in the Caucasian cluster were
glutamate, glutamine, glucose, and phosphocholine.
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3.5. Milk Metabolite Variation by Ethnicity in Healthy, Non-Atopic Women
2-Oxoglutarate (p = 0.008) and creatine (p = 0.02)/creatine phosphate (p = 0.008)/creatinine
(p = 0.03), as well as betaine (p = 0.01) and glycerophosphocholine (p = 0.009) concentrations were
higher in the milk of Black compared to Caucasian women (Table 2). Although lactose levels were also
higher, this difference did not reach statistical significance (p = 0.07). In contrast, milk valine levels
were lower in Black than in Caucasian women. In essence, these results compare mixed-race South
African to Caucasian women, because only one US Black-race woman was a member of the Black race
group. Compared to that of Asian women, the milk of Caucasians had significantly lower levels of
lactate (p = 0.03) and fucose (p = 0.03).
Table 2. Comparison of milk metabolite concentrations (µmol/L) by maternal ethnicity.
MEAN (SD)
Metabolites/Countries Black Caucasian Asian
2-Oxoglutarate 75.4 (31.1) 37.6 (29.2) ** 55.3 (47.1)
Acetone 12.9 (5.3) 11.9 (7.4) 14.2 (13.0)
Alanine 164.4 (87.9) 210.6 (82.1) 222.3 (90.9)
Betaine 581.1 (283.6) 204.9 (352.7) * 354.3 (390.1)
Caprate 77.2 (87.8) 109.8 (112.3) 185.1 (168.3)
Caprylate 134.7 (136.2) 118.1 (184.1) 266.9 (375.3)
Choline 285.1 (167.0) 170.2 (154.4) 218.7 (145.5)
Citrate 4892 (3687) 3123 (1833) 2776 (1061)
Creatine 229.4 (326.5) 77.6 (101.1) * 63.2 (28.5) *
Creatine phosphate 54.0 (56.2) 24.1 (13.7) ** 35.9 (26.8)
Creatinine 89.7 (68.2) 51.6 (37.0) * 44.2 (15.0) *
Formate 86.5 (79.3) 582.6 (1363) 534.5 (1350)
Fucose 328.0 (376.9) 306.0 (236.6) # 556.4 (391.5)
Glucose 1264 (672.2) 1263 (866.0) 1148 (1083)
Glutamate 1021 (614.5) 1478 (791.6) 1272 (536.3)
Glutamine 252.4 (122.0) 204.7 (310.6) 89.5 (79.2)
Glycine 2646 (1051) 2360 (1307) 2596 (1169)
Guanidoacetate 4405 (1378) 2912 (2538) 4544 (1916)
Isoleucine 17.3 (11.5) 20.5 (18.4) 23.4 (21.8)
Lactate 198.2 (82.2) 339.5 (600.5) # 1918 (4213)
Lactose 178,365 (50,934) 110,060 (86,787) 131,284 (85,509)
Leucine 31.5 (14.8) 52.1 (56.4) 64.0 (87.0)
Methanol 80.4 (15.7) 59.3 (23.6) 71.0 (46.6)
Phosphocholine 584.6 (305.1) 521.9 (304.1) 642.5 (435.6)
Pyruvate 46.5 (25.3) 21.4 (29.6) 47.2 (58.8)
Succinate 36.1 (53.0) 152.7 (446.7) 100.8 (124.4)
Valine 34.6 (12.0) 61.1 (26.2) * 63.9 (40.5)
Glycerophosphocholine 846.4 (424.6) 467.7 (319.9) ** 518.9 (327.7)
# metabolite differences with Black race na 7 2
# metabolite differences with Asian race 3 na 2
* p < 0.05, ** p < 0.01, when reference = Black; # p < 0.05, when reference = Asian; na: not applicable.
4. Discussion
In this comparison of 109 human milk samples from five countries, clustering by country of origin
was observed, such that milk metabolites in South African women differed substantially from those
in Norwegian and US women, and women in either of the two Australian cohorts. Milk metabolites
in Japanese women formed an overlapping cluster between Norway and South Africa. Creatine and
2-oxoglutarate were the milk metabolites mainly responsible for these regional differences; they were
also the highest in South African women among the cohort. Differences in these milk metabolites were
evident in a comparison of healthy, non-atopic women in all countries studied; lactose milk levels
were also the highest in South African women. Since several low molecular weight metabolites levels
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are tightly controlled in human milk [3], identifying differences between maternal countries of origin
are noteworthy. In the pursuant paragraphs, we summarize what is known about these metabolites,
highlight other findings, and offer candidate explanations for the higher levels seen in South African
women when compared to women living in Australia or the northern hemisphere.
After protein, lactose is the most plentiful component of human milk and often measured to
reflect the carbohydrate energy content. Human milk lactose is found to be associated with infant
growth in observational and simulation studies [22,23]. Since levels rise during the postpartum period
in breastfeeding women [24], lactose has also been labelled as a marker for milk production. In our
comparison, all human milk samples were obtained within one month of birth, removing timing of
collection as an explanation for differences in milk lactose or other metabolite concentrations. In two
to five months old infants, Gridneva et al. documented higher lactose milk levels in Australian women
who breastfed more frequently [16]. Their results are congruent with a metabolomics study of sow
milk, whereby Tan et al. reported higher milk lactose levels with higher rather than lower lactation
performance [25]. Glucose and fucose, other sugars typically found in human milk, did not differ in
their levels across country cohorts in our study. Lactose has also been found to have antimicrobial
and innate immunity-inducing properties [2,26,27]. Hence, the much greater levels of milk lactose
in South African women than in women living in more industrialized societies may reflect a greater
breastfeeding frequency, or maternal programming to prevent infection.
Although milk sugars are the main substrates for energy generation and the production of
oligosaccharides [28], little is known about these intermediate metabolites of the tricarboxylic acid
energy cycle (TCA cycle), such as 2-oxoglutarate, citrate, or succinate. In our study, lactose levels were
positively correlated with milk citrate and 2-oxoglutarate. Milk 2-oxoglutarate and citrate levels were
also highest in South African women in our comparison; however, no differences were observed in
milk succinate concentrations. As shown in a study of US women, the levels of milk 2-oxoglutarate
in women feeding term infants typically decline within one month of birth [20]. Of note, lower
2-oxoglutarate levels have been detected in the milk of dairy cows with mastitis (breast duct infection),
which is interpreted to be a function of greater consumption of this TCA cycle intermediate by resident
microbiota or infecting microbes [3,29]. Mastitis and subclinical mastitis are common infections
postpartum in industrialized countries [30], which offers another explanation for 2-oxoglutarate
consumption and lower milk concentrations in US, Australian, and Norwegian women. Japanese
women had higher milk levels of other energy-related intermediates such as lactate and pyruvate
than Norwegian women; not much is known about the milk levels of these metabolites in humans.
Compared to non-lactating cows, the TCA and related cycles, including pyruvate metabolism, were
found to be most activated in the mammary glands of lactating cows [31]; pyruvate and lactate were
among the 118 metabolites shared between the mammary gland and milk.
Lactose is produced by mammary cells, but other low-weight molecules are speculated to diffuse
into human milk and serve as indicators of maternal plasma levels [2]. Methanol is found in human
milk and can originate from maternal circulation following the consumption of fruits, vegetables,
alcohol, and artificial sweeteners, and from exposure to environmental tobacco smoke [32]. Other
examples are betaine, a choline metabolite whose levels increase with dietary intake of choline [33].
Consistently, milk betaine and the phosphocholines were positively correlated in our study. We
also found milk methanol to be lowest in Norwegian women, whereas betaine levels were lowered
in Australian milk. Milk creatinine (derived from creatine, an energy metabolite) levels are also
related to circulating blood levels [34]; urinary creatinine also reportedly rises postpartum during
breastfeeding [24]. In lactating cows, creatine and lactose are the two metabolites found in the stomach,
serum, milk, and urine, denoting their importance in the lactation process [31]. Of note, betaine is
an osmolytic and its supplementation can increase milk yield in cows [35]. Together with the higher
levels of milk lactose and betaine, elevated levels of milk creatine or its metabolite, creatinine, may
indicate higher milk production in South African women.
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In Tan et al.’s study of sow milk [25], glutamate and glutamine were additional markers of high
milk production. Glutamate is produced when 2-oxoglutarate combines with glutamine. Glutamine
and glutamate are the most abundant amino acids in human milk, increasing with each stage of
lactation, and are largely derived during lactation from muscle protein breakdown of glutamine [21,36].
Higher levels of the amino acid valine have also been found to be associated with higher bovine milk
yield [37]. It is then noteworthy that glutamate was the metabolite which distinguished US human milk
composition from that of Norwegian and Japanese women. Milk glutamine levels were significantly
lower in Norwegian and Japanese than in US women, which is consistent with the general observation
that glutamine levels are higher in North America than in Asia [21]. Both glutamine and glutamate
are important energy sources for intestinal cells and are needed for infant growth. When Dangat et
al. compared healthy women in India to women with maternal conditions such as pre-eclampsia,
which are associated with growth retardation in offspring, they found healthy women to have higher
glutamine and glutamate levels in their milk, as well as higher lactose concentrations [38].
Ethnic differences between the same milk metabolome of mixed Black and Caucasian women
were consistent with the country variation we observed, and further indicated a similarity among
Caucasian women in Norway, Australia, and the US, potentially in terms of breastfeeding practices
and/or maternal diet, health status, or genetics. Maternal diet has a reported influence on some human
milk constituents, such as fatty acids, vitamins, and minerals; maternal intake of carbohydrates or fat
is unrelated to milk lactose levels, but little is known about other low molecular weight substrates [13].
Since several low molecular metabolites detected in milk can be consumed or produced by resident
microbiota, ethnic differences in these milk metabolites may also be a function of variation in human
milk microbiota. As shown by Kumar et al., human milk microbial composition can vary according to
the degree of societal industrialization, whereby the abundance of Proteobacteria is observed to be
higher in milk samples of South African women [4]. In this regard, human milk lactose levels have
been reported by others to vary inversely with milk Enterobacteria [26]. Further, maternal intake of
lactose has been inversely correlated with milk concentrations within the Firmicutes phylum [39].
Unfortunately, data on maternal diet was not collected at the time that human milk samples were
obtained in our study. Additionally, no women of Asian ethnicity were present in the Australian or US
cohorts, and too few non-atopic women of Black race were recruited in the US cohort to speculate on
genetic versus environmental origins of the milk metabolite variation.
The strengths of this international comparative study are that all human milk samples were
selected at the same stage of lactation with similar maternal characteristics, and processed with NMR
spectroscopy in one center. As has been reported for other milk constituents [40], despite not following
an identical protocol for milk collection, the individual country samples were similar across several
milk metabolites whose levels have been reported to be tightly controlled [20].
5. Conclusions
Human milk composition is optimal for infant growth and development. As we and others seek
to determine how societal factors impact on the infant gut microbiome, immune development and
subsequent health, understanding population differences in early nutrition is essential. This present
work should be considered a first step in helping to frame breastfeeding/microbiome studies in a
global context. It reminds us that regional maternal diet and breastfeeding practices have the capacity
to influence milk composition. In addition to trying to understand this variation, we must also leverage
study findings to inform policy, especially in times of change. In our study, the milk composition of
South African women had higher levels of lactose, creatine and energy metabolites. How will South
African infants fare against the rising trends of not being fed colostrum, receiving short exclusive
breastfeeding and being introduced to solids at an early stage [41] in a country historically known for
lower infant growth failure rates than it neighbors [42]? Understanding people and their place and
purpose on this planet is essential to understanding the complexity we face in harnessing the health of
the microbiome.
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